BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34524978)

  • 1. Assessment of different markers of ovarian reserve in women with papillary thyroid cancer treated with radioactive iodine.
    Adamska A; Tomczuk-Bobik P; Popławska-Kita AB; Siewko K; Buczyńska A; Szumowski P; Żukowski Ł; Myśliwiec J; Zbucka-Krętowska M; Adamski M; Krętowski AJ
    Endocr Connect; 2021 Oct; 10(10):1283-1290. PubMed ID: 34524978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single Radioactive Iodine Treatment Has a Deleterious Effect on Ovarian Reserve in Women with Thyroid Cancer: Results of a Prospective Pilot Study.
    Yaish I; Azem F; Gutfeld O; Silman Z; Serebro M; Sharon O; Shefer G; Limor R; Stern N; Tordjman KM
    Thyroid; 2018 Apr; 28(4):522-527. PubMed ID: 29466932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Radioactive Iodine Therapy on Ovarian Reserve: A Prospective Pilot Study.
    Evranos B; Faki S; Polat SB; Bestepe N; Ersoy R; Cakir B
    Thyroid; 2018 Dec; 28(12):1702-1707. PubMed ID: 30156472
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Ovarian Reserve with AMH Level in Patients with Well-Differentiated Thyroid Cancer Receiving Radioactive Iodine Ablation Treatment.
    Acıbucu F; Acıbucu DO; Akkar ÖB; Dokmetas HS
    Exp Clin Endocrinol Diabetes; 2016 Nov; 124(10):593-596. PubMed ID: 27711957
    [No Abstract]   [Full Text] [Related]  

  • 5. Decline in anti-Müllerian hormone concentrations following radioactive iodine treatment in women with differentiated thyroid cancer: A systematic review and meta-analysis.
    Anagnostis P; Florou P; Bosdou JK; Grimbizis GF; Iakovou I; Kolibianakis EM; Goulis DG
    Maturitas; 2021 Jun; 148():40-45. PubMed ID: 34024350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer.
    van Velsen EFS; Visser WE; van den Berg SAA; Kam BLR; van Ginhoven TM; Massolt ET; Peeters RP
    Thyroid; 2020 Apr; 30(4):580-587. PubMed ID: 31928168
    [No Abstract]   [Full Text] [Related]  

  • 7. The correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile women.
    Barbakadze L; Kristesashvili J; Khonelidze N; Tsagareishvili G
    Int J Fertil Steril; 2015; 8(4):393-8. PubMed ID: 25780521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical Hypothyroidism Is Associated with Lower Ovarian Reserve in Women Aged 35 Years or Older.
    Rao M; Wang H; Zhao S; Liu J; Wen Y; Wu Z; Yang Z; Su C; Su Z; Wang K; Tang L
    Thyroid; 2020 Jan; 30(1):95-105. PubMed ID: 31650898
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-Müllerian hormone in pre-menopausal females after ablative radioiodine treatment for differentiated thyroid cancer.
    Giusti M; Mittica M; Comite P; Campana C; Gay S; Mussap M
    Endocrine; 2018 Jun; 60(3):516-523. PubMed ID: 29302874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
    Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Mullerian hormone, inhibin B, and antral follicle count in young women with ovarian failure.
    Knauff EA; Eijkemans MJ; Lambalk CB; ten Kate-Booij MJ; Hoek A; Beerendonk CC; Laven JS; Goverde AJ; Broekmans FJ; Themmen AP; de Jong FH; Fauser BC;
    J Clin Endocrinol Metab; 2009 Mar; 94(3):786-92. PubMed ID: 19066296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
    Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
    Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-mullerian hormone: a new marker of ovarian function.
    Dayal M; Sagar S; Chaurasia A; Singh U
    J Obstet Gynaecol India; 2014 Apr; 64(2):130-3. PubMed ID: 24757342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of ovarian reserve markers (AMH, FSH, AFC) in different age strata in IVF/ICSI patients.
    Shahrokh Tehraninezhad E; Mehrabi F; Taati R; Kalantar V; Aziminekoo E; Tarafdari A
    Int J Reprod Biomed; 2016 Aug; 14(8):501-6. PubMed ID: 27679824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
    Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
    Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ; Stojanovic N; Dewailly D
    Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Radioactive Iodine Therapy on Ovarian Function and Fertility in Female Thyroid Cancer Patients: A Systematic Review and Meta-Analysis.
    Piek MW; Postma EL; van Leeuwaarde R; de Boer JP; Bos AME; Lok C; Stokkel M; Filipe MD; van der Ploeg IMC
    Thyroid; 2021 Apr; 31(4):658-668. PubMed ID: 33012254
    [No Abstract]   [Full Text] [Related]  

  • 20. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.